Skip to main content

A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients with Multiple System Atrophy

Open
  • Protocol code: TV56286-NDG-20039
  • EudraCT code: No aplica
  • Research group: Neurodegenerative Diseases
  • Service: Neurology
  • Principal investigator:  Hernández Vara, Jorge
  • Pathology: Malalties del sistema nerviós
  • Phase: Fase II